Wegovy Direct to Consumer: What the UK Access Route Actually Looks Like

What 'direct to consumer' can and cannot mean for a prescription medicine

The phrase "direct to consumer" usually suggests buying something without going through a clinic or GP. With Wegovy, that picture needs adjusting. UK law requires a prescriber to assess you before any supply, not as a technicality, but because GLP-1 medicines interact with other conditions, medicines and circumstances in ways that genuinely matter. What has changed in recent years is that the prescriber no longer needs to sit across a desk from you. Regulated online pharmacies with their own GPhC-registered prescribers can conduct that assessment remotely, complete the prescription, and dispatch the medicine the same day. That is the closest thing to a true direct-to-consumer route that the law permits, and, done properly, it is entirely legitimate.

What is not legitimate is any seller offering Wegovy, or semaglutide under any name, without requiring a prescription at all. The MHRA has flagged this pattern repeatedly, including in its public guidance on GLP-1 medicines and safety. Fake pens have been seized in their millions across the UK; some contained insulin rather than semaglutide, and people were hospitalised. A low price and a quick checkout are the wrong signals to follow.

The practical upshot: when you see "Wegovy direct to consumer", the question to ask is not whether a prescription is involved, but whether the prescriber and pharmacy behind it are properly registered.

The factors that should guide your decision about where to get treatment

Once you know that every legal supply involves a prescriber, the decision shifts to who that prescriber is and what the service around them looks like. A few things are worth weighing carefully.

First, identity and weight verification. A responsible service confirms who you are and checks your weight, not just asks you to type a number. Photo-ID checks and live weight verification on video exist because dose decisions and eligibility assessments depend on accurate data.

Second, what happens after your first pen. Wegovy is a titrated treatment: the dose moves through a schedule over several months, and how that progression is managed matters. A service that offers a single transaction and disappears is not managing your treatment; it is selling you a product.

Third, what the price actually covers. Some headline figures exclude the consultation, the prescription fee, delivery and clinical aftercare. Comparing prices without knowing what is included is not a straightforward exercise. There is a more detailed breakdown of what private weight-loss treatment costs in context on our treatment page.

None of this is to suggest that private online care is inferior to a GP visit. Done well, it is faster and equally thorough. The point is that the structure of care should be visible and verifiable before you commit.

Who Wegovy is licensed for, and what the prescriber is checking

The licensed criteria for Wegovy in the UK cover adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. NICE's appraisal of semaglutide (TA875) also sets out the NHS conditions for access, which are narrower than the licensed criteria and require specialist service involvement.

A prescriber working through a private online service is checking more than the BMI figure. They are looking at your medical history, current medicines, any conditions that would make treatment unsuitable, and whether your weight-related health picture supports the benefit-risk balance. History of certain thyroid or pancreatic conditions, for instance, requires careful assessment. That is why the wegovy consultation is not a formality; it is where the clinical decision actually happens.

Pregnancy, breastfeeding and trying to conceive are all situations where Wegovy is not recommended. The medicine is not licensed for under-18s. If you have questions about potential drawbacks or contraindications, our information pages go into more detail, and a prescriber can give you a personal view at consultation. For a broader look at the limitations and downsides of semaglutide, we cover those in a dedicated section too.

How a reputable private service handles the process from start to delivery

At nume, the process follows a clear sequence. You complete a free online consultation. A GPhC-registered Independent Prescriber reads it the same day, not software, a named clinician. If treatment is appropriate, your prescription is issued, your identity and weight are verified, and the medicine is dispatched from our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register). Orders placed before 12pm on a working day go out the same day; DPD delivers free to your door the next working day, tracked, in plain packaging. One of our patients described keeping her pen in the fridge door at eye level so the weekly routine became automatic, a small detail, but the kind of thing that actually helps.

Every repeat order goes through clinical review again. There are no subscriptions, no automatic dispatches and no dose increases without evidence. If you want to understand how to administer Wegovy correctly before you start, that information is on hand before your first pen arrives. And if questions come up mid-treatment, aftercare support is available seven days a week.

You can verify any online pharmacy at the GPhC register before you order from them. That single check takes less than a minute and is the clearest signal of legitimacy available.

If you are ready to find out whether Wegovy is clinically suitable for you, start your free consultation with our prescribers.